{ "docId": "019dd923-5ca1-7489-b639-45501f4b359b", "docSlug": "158df8627a0b9aca", "documentTitle": "Opioid Conflicts Majority Staff Report", "authorId": "McKinsey", "authorName": "U.S. House Committee on Oversight and Reform", "documentKindSlug": "consulting-deck", "documentKindLabel": "Consulting deck", "sourceTypeSlug": "strategy_consulting", "sourceTypeLabel": "Strategy consulting", "presentationDate": null, "orientation": "portrait", "aspectRatio": 0.773, "pageNumber": 5, "pageCount": 53, "prevPage": 4, "nextPage": 6, "slideType": "appendix_disclosure", "function": "summarize", "density": "dense", "nDataPoints": 0, "notes": "This appears to be a page from a congressional or investigative report.", "elementsJson": [ "bullet_list", "paragraph" ], "metadataConfidence": 1, "imagePath": null, "slideHref": "/slides/019dd923-5ca1-7489-b639-45501f4b359b/5", "deckHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b", "deckJsonHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b.json", "deckAnchorHref": "/decks/019dd923-5ca1-7489-b639-45501f4b359b#slide-5", "components": [ { "bbox": null, "kind": "callout", "text": "McKinsey failed to disclose its serious, longstanding conflicts of interests to FDA, potentially violating contract requirements and federal law.", "attrs": null, "subkind": null, "toolName": "Visual emphasis", "toolSlug": "visual-emphasis", "confidence": null, "componentId": "019dd951-cdec-74db-b49a-7c701da137e7", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.22, "w": 0.63, "x": 0.238, "y": 0.326 }, "kind": "list", "text": "McKinsey failed to disclose its serious, longstanding conflicts of interests to FDA, potentially violating contract requirements and federal law: The Federal Acquisition Regulation (FAR) sets rules for federal agencies, including the FDA, to avoid, neutralize, and mitigate organizational conflicts of interest before awarding contracts. Pursuant to those regulations, many of McKinsey’s FDA contracts affirmatively required contractors submitting proposals to disclose potential organizational conflicts of interest. However, McKinsey produced no evidence to the Committee that it ever disclosed its extensive, ongoing work for opioid manufacturers to FDA. McKinsey appears to have repeatedly certified that there were “no relevant facts or circumstances which would give rise to an organizational conflict of interest.” False certifications on federal contracts can lead to civil or criminal penalties, including under the False Claims Act.", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "1e891edb-4162-44d8-a516-4e39ef719ee2", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.22, "w": 0.63, "x": 0.238, "y": 0.568 }, "kind": "list", "text": "McKinsey consultants discussed deleting documents related to their work for Purdue: Documents obtained by the Committee reveal that as early as May 2017, McKinsey partners discussed ways to keep McKinsey’s documents from being discovered in Purdue’s ongoing lawsuits, including putting presentations on a “neutral template” without Purdue’s logo and only showing “hard” or paper copies of presentations to Purdue. One McKinsey senior partner described the perceived benefit of the latter approach: “It will live only on our laptops and then we can delete.” Public reporting has shown that in July 2018, senior partners at McKinsey discussed destroying their documents related to their work for Purdue. Documents obtained by the Committee show one of these senior partners later emailed himself a note to “delete old pur documents from laptop.”", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "2a1857a3-2a4c-44f1-8263-346de30e9ffd", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.08, "w": 0.63, "x": 0.238, "y": 0.203 }, "kind": "list", "text": "McKinsey consultants discussed the firm’s influence on a speech by FDA Commissioner Gottlieb in 2018 concerning a drug safety monitoring program. They noted that a claim about opioids made by another McKinsey consultant who had worked for both FDA and an opioid manufacturer “got into one of Scott Gottlieb’s public speeches” even though the consultant had “made it up entirely.”", "attrs": null, "subkind": "bullet", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "410be54e-d5f7-45d6-bc8b-213e77d14707", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.05, "w": 0.63, "x": 0.238, "y": 0.116 }, "kind": "paragraph", "text": "recommended that the memo to Secretary Azar emphasize the “important societal benefit” of opioids. The final memo included certain recommendations that appear aligned with the interests of McKinsey’s private sector opioid clients.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "822b55b7-c84c-42fc-824e-94f3613da8a4", "frameworkName": null, "frameworkSlug": null }, { "bbox": { "h": 0.07, "w": 0.75, "x": 0.118, "y": 0.778 }, "kind": "paragraph", "text": "Despite evidence of conflicts of interest resulting from McKinsey’s work for the federal government and private sector clients, and the possibility that such conflicts may have contributed to America’s deadly opioid epidemic, McKinsey has refused to fully cooperate with the Committee’s investigation. In particular, McKinsey has failed to provide basic information about certain clients and the work McKinsey did for them.", "attrs": null, "subkind": "paragraph", "toolName": null, "toolSlug": null, "confidence": null, "componentId": "ff096077-7d77-45f0-b0e1-0a187ae01b0d", "frameworkName": null, "frameworkSlug": null }, { "bbox": null, "kind": "quote", "text": "It will live only on our laptops and then we can delete.", "attrs": null, "subkind": null, "toolName": "Authority citation", "toolSlug": "authority-citation", "confidence": null, "componentId": "019dd951-cdec-74db-b49a-803d6b630c52", "frameworkName": null, "frameworkSlug": null } ], "metrics": [], "tools": [], "frameworks": [], "arcBeats": [ { "to": 5, "from": 1, "beatId": "879d5693-fa0d-471e-8bc6-dddb3a68ee78", "arcName": "Problem-Agitate-Solution", "arcSlug": "problem-agitate-solution", "beatName": "Problem & Complication", "beatSlug": "consultants-gambit-problem-complication", "evidence": "The document introduces the problem of McKinsey's conflicts of interest and complicates it through examples of overlapping work.", "position": 0, "confidence": 0.8, "parentBeatName": "Complication", "parentBeatSlug": "complication" } ], "loops": [ { "to": 53, "from": 1, "name": "Cost Of Inaction", "slug": "27-cost-of-inaction", "bestFor": "Urgent budget requests, compliance, risk mitigation", "matchId": "ee9686db-f8b5-4bc9-bf6e-2d29966ee033", "evidence": "The document implies the cost of inaction through its presentation of McKinsey's conflicts of interest and their potential impact on the opioid epidemic.", "position": 0, "objective": "What is the cost of inaction in addressing McKinsey's conflicts of interest?", "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point", "confidence": 0.7, "description": "Quantify what happens if the audience does nothing" } ], "imagePathAlt": null, "thumbSrc": null, "thumbSrcAlt": null, "locked": true }